Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography

Simmons, 2007, Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy, Eur Urol, 51, 1175, 10.1016/j.eururo.2007.01.015

Suardi, 2008, A nomogram predicting long-term biochemical recurrence after radical prostatectomy, Cancer, 112, 1254, 10.1002/cncr.23293

Boorjian, 2011, Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence, Eur Urol, 59, 893, 10.1016/j.eururo.2011.02.026

Han, 2001, Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience, Urol Clin North Am, 28, 555, 10.1016/S0094-0143(05)70163-4

Pound, 1999, Natural history of progression after PSA elevation following radical prostatectomy, JAMA, 281, 1591, 10.1001/jama.281.17.1591

Mottet, 2011, EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer, Eur Urol, 59, 572, 10.1016/j.eururo.2011.01.025

Mohler, 2010, NCCN clinical practice guidelines in oncology: prostate cancer, J Natl Compr Canc Netw, 8, 162, 10.6004/jnccn.2010.0012

Sandler, 2007, Assessing and treating patients with increasing prostate specific antigen following radical prostatectomy, J Urol, 178, S20, 10.1016/j.juro.2007.04.034

Picchio, 2011, The role of choline positron emission tomography/computed tomography in the management of patients with prostate-specific antigen progression after radical treatment of prostate cancer, Eur Urol, 59, 51, 10.1016/j.eururo.2010.09.004

Scattoni, 2007, Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy, Eur Urol, 52, 423, 10.1016/j.eururo.2007.03.032

Schumacher, 2008, Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy, Eur Urol, 54, 344, 10.1016/j.eururo.2008.05.023

Briganti, 2009, Eur Urol, 55, 261, 10.1016/j.eururo.2008.09.043

Briganti A, Suardi N, Capogrosso P, et al. Lymphatic spread of nodal metastases in high-risk prostate cancer: the ascending pathway from the pelvis to the retroperitoneum. Prostate. In press. DOI:10.1002/pros.21420.

Bochner, 2004, Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping, J Urol, 172, 1286, 10.1097/01.ju.0000137817.56888.d1

Dindo, 2004, Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey, Ann Surg, 240, 205, 10.1097/01.sla.0000133083.54934.ae

Hanlon, 2002, Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer, Int J Radiat Oncol Biol Phys, 53, 297, 10.1016/S0360-3016(02)02717-7

Kwak, 2002, Prognostic significance of the nadir prostate specific antigen level after hormone therapy for prostate cancer, J Urol, 168, 995, 10.1016/S0022-5347(05)64559-4

Park SY, Choi GS, Jun SH, Park JS, Kim HJ. Laparoscopic salvage surgery for recurrent and metachronous colorectal cancer: 15 years’ experience in a single center. Surg Endosc. In press.

Eeson, 2011, Outcomes of salvage surgery for epidermoid carcinoma of the anus following failed combined modality treatment, Am J Surg, 201, 624, 10.1016/j.amjsurg.2011.01.015

Yim, 2011, The outcomes of first reoperation for locoregionally recurrent/persistent papillary thyroid carcinoma in patients who initially underwent total thyroidectomy and remnant ablation, J Clin Endocrinol Metab, 96, 2049, 10.1210/jc.2010-2298

Keating, 2010, Diabetes and cardiovascular disease during androgen deprivation therapy: observational study of veterans with prostate cancer, J Natl Cancer Inst, 102, 39, 10.1093/jnci/djp404

de Jong, 2003, 11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer, Eur Urol, 44, 32, 10.1016/S0302-2838(03)00207-0

Krause, 2008, The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer, Eur J Nucl Med Mol Imaging, 35, 18, 10.1007/s00259-007-0581-4

Suardi, 2011, Salvage lymphadenectomy in postprostatectomy patients with prostate-specific antigen recurrence, Curr Opin Urol, 21, 237, 10.1097/MOU.0b013e328344e4c4

Rinnab, 2009, [(11)C]choline PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy, World J Urol, 27, 619, 10.1007/s00345-009-0371-7

Winter, 2010, First results of [11C]choline PET/CT-guided secondary lymph node surgery in patients with PSA failure and single lymph node recurrence after radical retropubic prostatectomy, Urol Int, 84, 418, 10.1159/000296298

Jereczek-Fossa BA, Beltramo G, Fariselli L, et al. Robotic image-guided stereotactic radiotherapy, for isolated recurrent primary, lymph node or metastatic prostate cancer. Int J Radiat Oncol Biol Phys. In press.

Mattei, 2008, The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study, Eur Urol, 53, 118, 10.1016/j.eururo.2007.07.035

Snyder, 2010, How does initial treatment choice affect short-term and long-term costs for clinically localized prostate cancer?, Cancer, 116, 5391, 10.1002/cncr.25517